Kirkland Represents CF PharmTech on its Hong Kong Listing | News

Kirkland & Ellis advised CF PharmTech, Inc. (CF PharmTech, HKEx: 2652) on its global offering and listing on the Main Board of the Hong Kong Stock Exchange. The joint sponsors for the listing were CITIC…

Continue Reading